Literature DB >> 23313489

Application of multianalyte microphysiometry to characterize macrophage metabolic responses to oxidized LDL and effects of an apoA-1 mimetic.

Danielle W Kimmel1, William P Dole, David E Cliffel.   

Abstract

Although the interaction of macrophages with oxidized low density liopoprotein (oxLDL) is critical to the pathogenesis of atherosclerosis, relatively little is known about their metabolic response to oxLDL. Our development of the multianalyte microphysiometer (MAMP) allows for simultaneous measurement of extracellular metabolic substrates and products in real-time. Here, we use the MAMP to study changes in the metabolic rates of RAW-264.7 cells undergoing respiratory burst in response to oxLDL. These studies indicate that short duration exposure of macrophages to oxLDL results in time-dependent increases in glucose and oxygen consumption and in lactate production and extracellular acidification rate. Since apolipoprotein A-I (apoA-I) and apoA-I mimetics prevent experimental atherosclerosis, we hypothesized that the metabolic response of the macrophage during respiratory burst can be modulated by apoA-I mimetics. We tested this hypothesis by examining the effects of the apoA-I peptide mimetic, L-4F, alone and complexed with 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) on the macrophage metabolic response to oxLDL. L-4F and the DMPC/L-4F complexes attenuated the macrophage respiratory burst in response to oxLDL. The MAMP provides a novel approach for studying macrophage ligand-receptor interactions and cellular metabolism and our results provide new insights into the metabolic effects of oxLDL and mechanism of action of apoA-I mimetics.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23313489      PMCID: PMC3576722          DOI: 10.1016/j.bbrc.2012.12.140

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

1.  Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH.

Authors:  J J Casciari; S V Sotirchos; R M Sutherland
Journal:  J Cell Physiol       Date:  1992-05       Impact factor: 6.384

2.  Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein.

Authors:  M P Ramprasad; V Terpstra; N Kondratenko; O Quehenberger; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.

Authors:  M T Quinn; S Parthasarathy; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  Acute effects of oxidized low density lipoprotein on metabolic responses in macrophages.

Authors:  H E De Vries; E Ronken; J H Reinders; B Buchner; T J Van Berkel; J Kuiper
Journal:  FASEB J       Date:  1998-01       Impact factor: 5.191

5.  Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function.

Authors:  Catherine E Watson; Nicole Weissbach; Lise Kjems; Surya Ayalasomayajula; Yiming Zhang; Ih Chang; Mohamad Navab; Susan Hama; Greg Hough; Srinivasa T Reddy; Daniel Soffer; Daniel J Rader; Alan M Fogelman; Alison Schecter
Journal:  J Lipid Res       Date:  2010-11-10       Impact factor: 5.922

6.  CD36 is a receptor for oxidized low density lipoprotein.

Authors:  G Endemann; L W Stanton; K S Madden; C M Bryant; R T White; A A Protter
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

Review 7.  Inflammation and atherosclerosis.

Authors:  Göran K Hansson; Anna-Karin L Robertson; Cecilia Söderberg-Nauclér
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

8.  Metabolism of normal and modified low-density lipoproteins by macrophage cell lines of murine and human origin.

Authors:  D P Via; A L Plant; I F Craig; A M Gotto; L C Smith
Journal:  Biochim Biophys Acta       Date:  1985-03-06

9.  A microphysiometer for simultaneous measurement of changes in extracellular glucose, lactate, oxygen, and acidification rate.

Authors:  Sven E Eklund; Dale Taylor; Eugene Kozlov; Ales Prokop; David E Cliffel
Journal:  Anal Chem       Date:  2004-02-01       Impact factor: 6.986

10.  Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits.

Authors:  Brian J Van Lenten; Alan C Wagner; Mohamad Navab; G M Anantharamaiah; Susan Hama; Srinivasa T Reddy; Alan M Fogelman
Journal:  J Lipid Res       Date:  2007-08-10       Impact factor: 5.922

View more
  5 in total

1.  A microfluidic optical platform for real-time monitoring of pH and oxygen in microfluidic bioreactors and organ-on-chip devices.

Authors:  Seyed Ali Mousavi Shaegh; Fabio De Ferrari; Yu Shrike Zhang; Mahboubeh Nabavinia; Niema Binth Mohammad; John Ryan; Adel Pourmand; Eleanor Laukaitis; Ramin Banan Sadeghian; Akhtar Nadhman; Su Ryon Shin; Amir Sanati Nezhad; Ali Khademhosseini; Mehmet Remzi Dokmeci
Journal:  Biomicrofluidics       Date:  2016-08-26       Impact factor: 2.800

2.  IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.

Authors:  Katherine T Venmar; Danielle W Kimmel; David E Cliffel; Barbara Fingleton
Journal:  Biochim Biophys Acta       Date:  2015-03-04

3.  The relevance and potential roles of microphysiological systems in biology and medicine.

Authors:  John P Wikswo
Journal:  Exp Biol Med (Maywood)       Date:  2014-09

Review 4.  Apolipoprotein A-I mimetics.

Authors:  Srinivasa T Reddy; Mohamad Navab; Gattadahalli M Anantharamaiah; Alan M Fogelman
Journal:  Curr Opin Lipidol       Date:  2014-08       Impact factor: 4.776

Review 5.  Multianalyte Physiological Microanalytical Devices.

Authors:  Anna Nix Davis; Adam R Travis; Dusty R Miller; David E Cliffel
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2017-06-12       Impact factor: 12.400

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.